Literature DB >> 11059443

Apoptosis in rheumatic diseases.

T Grodzicky1, K B Elkon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11059443     DOI： 10.1016/s0002-9343(99)00332-0

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  8 in total

Review 1.  Apoptosis-detecting radioligands: current state of the art and future perspectives.

Authors:  Christophe M M Lahorte; Jean-Luc Vanderheyden; Neil Steinmetz; Christophe Van de Wiele; Rudi A Dierckx; Guido Slegers
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-05-12       Impact factor: 9.236

2.  Elevated levels of soluble Fas (APO-1, CD95), soluble Fas ligand, and matrix metalloproteinase-3 in sera from patients with active untreated adult onset Still's disease.

Authors:  Der-Yuan Chen; Joung-Liang Lan; Fang-Ju Lin; Tsu-Yi Hsieh
Journal:  Clin Rheumatol       Date:  2006-09-14       Impact factor: 2.980

3.  Ursolic acid facilitates apoptosis in rheumatoid arthritis synovial fibroblasts by inducing SP1-mediated Noxa expression and proteasomal degradation of Mcl-1.

Authors:  Eugene Y Kim; Kuladeep Sudini; Anil K Singh; Mahamudul Haque; Douglas Leaman; Sadik Khuder; Salahuddin Ahmed
Journal:  FASEB J       Date:  2018-05-25       Impact factor: 5.191

4.  Structural basis for autoantibody recognition of phosphatidylserine-beta 2 glycoprotein I and apoptotic cells.

Authors:  B A Cocca; S N Seal; P D'Agnillo; Y M Mueller; P D Katsikis; J Rauch; M Weigert; M Z Radic
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

5.  Anti-platelet antibodies associated with the Canale-Smith syndrome bind to the same platelet glycoprotein complexes as those of idiopathic thrombocytopenic purpura patients.

Authors:  T Grodzicky; J B Bussel; K B Elkon
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

6.  Anti-nucleosome antibodies as prediction factor of development of autoantibodies during therapy with three different TNFalpha blocking agents in rheumatoid arthritis.

Authors:  Maurizio Benucci; Gianantonio Saviola; Paola Baiardi; Emanuela Cammelli; Mariangela Manfredi
Journal:  Clin Rheumatol       Date:  2007-10-10       Impact factor: 2.980

7.  Reduced pH and chloride levels in exhaled breath condensate of patients with chronic cough.

Authors:  A Niimi; L T Nguyen; O Usmani; B Mann; K F Chung
Journal:  Thorax       Date:  2004-07       Impact factor: 9.139

Review 8.  Progress in nutritional immunology.

Authors:  Gabriel Fernandes
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.